Main Session
Sep
30
QP 37 - From Detection to Re-treatment: Managing Radiorecurrent Prostate Cancer
1217 - Eugonadal Progression-Free Survival Following Intensification of Metastasis-Directed Stereotactic Body Radiotherapy with Radioligand Therapy or Androgen Annihilation Therapy: A Comparison of Two Phase II Trials
Presenter(s)
Esther Yu, MD - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles, CA